These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16807408)

  • 1. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).
    Parkinson N; Ince PG; Smith MO; Highley R; Skibinski G; Andersen PM; Morrison KE; Pall HS; Hardiman O; Collinge J; Shaw PJ; Fisher EM; ;
    Neurology; 2006 Sep; 67(6):1074-7. PubMed ID: 16807408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS).
    Cox LE; Ferraiuolo L; Goodall EF; Heath PR; Higginbottom A; Mortiboys H; Hollinger HC; Hartley JA; Brockington A; Burness CE; Morrison KE; Wharton SB; Grierson AJ; Ince PG; Kirby J; Shaw PJ
    PLoS One; 2010 Mar; 5(3):e9872. PubMed ID: 20352044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
    Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
    Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
    Keller BA; Volkening K; Droppelmann CA; Ang LC; Rademakers R; Strong MJ
    Acta Neuropathol; 2012 Nov; 124(5):733-47. PubMed ID: 22941224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
    Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
    Wilhelmsen KC; Forman MS; Rosen HJ; Alving LI; Goldman J; Feiger J; Lee JV; Segall SK; Kramer JH; Lomen-Hoerth C; Rankin KP; Johnson J; Feiler HS; Weiner MW; Lee VM; Trojanowski JQ; Miller BL
    Arch Neurol; 2004 Mar; 61(3):398-406. PubMed ID: 15023818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology.
    Teyssou E; Takeda T; Lebon V; Boillée S; Doukouré B; Bataillon G; Sazdovitch V; Cazeneuve C; Meininger V; LeGuern E; Salachas F; Seilhean D; Millecamps S
    Acta Neuropathol; 2013 Apr; 125(4):511-22. PubMed ID: 23417734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.
    Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW
    Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
    Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
    Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological involvement of the motor neuron system and hippocampal formation in motor neuron disease-inclusion dementia.
    Toyoshima Y; Piao YS; Tan CF; Morita M; Tanaka M; Oyanagi K; Okamoto K; Takahashi H
    Acta Neuropathol; 2003 Jul; 106(1):50-6. PubMed ID: 12669241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H; Weber E; Korhonen L; Lindholm D
    Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3.
    Holm IE; Englund E; Mackenzie IR; Johannsen P; Isaacs AM
    J Neuropathol Exp Neurol; 2007 Oct; 66(10):884-91. PubMed ID: 17917582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis.
    Mizuno Y; Amari M; Takatama M; Aizawa H; Mihara B; Okamoto K
    J Neurol Sci; 2006 Nov; 249(1):13-8. PubMed ID: 16820172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
    Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum.
    Nakano T; Nakaso K; Nakashima K; Ohama E
    Acta Neuropathol; 2004 Apr; 107(4):359-64. PubMed ID: 14762676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B).
    Midani-Kurçak JS; Dinekov M; Puladi B; Arzberger T; Köhler C
    Brain Res; 2019 Mar; 1706():224-236. PubMed ID: 30414727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of peripherin in ubiquinated inclusions of amyotrophic lateral sclerosis.
    He CZ; Hays AP
    J Neurol Sci; 2004 Jan; 217(1):47-54. PubMed ID: 14675609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.